Implementation of halal principles in a nanotechnology-based drug delivery system
Review of materials, critical issues, and opportunities for development
Keywords:
Halal pharmaceuticals, drug delivery systems, nanotechnology, nanocarriers, halal critical pointsAbstract
The development of nanotechnology has led to the emergence of various drug delivery systems, including liposomes, lipid nanoparticles (LNPs), nanoemulsions, solid lipid nanoparticles (SLNs), and polymeric nanoparticles, which can improve drug solubility, bioavailability, stability, and therapeutic effectiveness. At the same time, the growing awareness of halal healthcare products among Muslim consumers has increased the need to evaluate the halal aspects of pharmaceutical products, including those based on nanotechnology. This review aims to examine the characteristics of different nanocarriers, identify the critical halal points of their constituent materials, and discuss the challenges and opportunities in the development of halal nanopharmaceuticals. A literature review approach was used by analysing scientific publications related to nanotechnology-based drug delivery systems and halal pharmaceuticals. The findings show that common nanocarrier materials include phospholipids, cholesterol, solid lipids, surfactants, polyethylene glycol (PEG), and various natural and synthetic polymers. Several of these materials may present critical halal concerns due to their animal-derived sources, manufacturing processes, or potential cross-contamination during production. Therefore, the implementation of halal principles in nanopharmaceutical products requires careful consideration of raw material sources, manufacturing processes, traceability, and halal certification. Integrating halal compliance with product quality, safety, and efficacy may support the development of nanotechnology-based drug delivery systems that fulfil the principles of halalan tayyiban.
Downloads
References
Alshawwa, S. Z., Kassem, A. A., Farid, R. M., Mostafa, S. K., & Labib, G. S. (2022). Nanocarrier Drug Delivery Systems: Characterization, Limitations, Future Perspectives and Implementation of Artificial Intelligence. Pharmaceutics, 14(4), 883. https://doi.org/10.3390/pharmaceutics14040883
Deng, S., Gigliobianco, M. R., Censi, R., & Di Martino, P. (2020). Polymeric Nanocapsules as Nanotechnological Alternative for Drug Delivery System: Current Status, Challenges and Opportunities. Nanomaterials, 10(5), 847. https://doi.org/10.3390/nano10050847
Egwu, C. O., Aloke, C., Onwe, K. T., Umoke, C. I., Nwafor, J., Eyo, R. A., Chukwu, J. A., Ufebe, G. O., Ladokun, J., Audu, D. T., Agwu, A. O., Obasi, D. C., & Okoro, C. O. (2024). Nanomaterials in Drug Delivery: Strengths and Opportunities in Medicine. Molecules, 29(11), 2584. https://doi.org/10.3390/molecules29112584
Herdiana, Y., & Rusdiana, T. (2022). Indonesian Halal Pharmaceutical: Challenges And Market Opportunities. Indonesian Journal of Pharmaceutics, 3(3), 99. https://doi.org/10.24198/idjp.v3i3.37660
Herdiana, Y., Sofian, F. F., Shamsuddin, S., & Rusdiana, T. (2024). Towards halal pharmaceutical: Exploring alternatives to animal-based ingredients. Heliyon, 10(1), e23624. https://doi.org/10.1016/j.heliyon.2023.e23624
Kasri, R. A., Amalia, N., Yuniar, A. M., & Mariz, K. (2023). Opportunities and Challenges for Developing Halal Pharmaceuticals Industry in Indonesia. 5(1).
Ma’arif, B., Azzahara, R., Rizki, F., Suryadinata, A., Wafi, A., Maulina, N., & Sugihantoro, H. (2023). Formulasi dan karakterisasi nanoemulsi ekstrak etanol 70% daun semanggi (Marsilea crenata C. Presl.): Formulation and characterization of 70% ethanol extract nanoemulsion of semanggi (Marsilea crenata C. Presl.) leaves. Medical Sains: Jurnal Ilmiah Kefarmasian, 8(2), 733–746. https://repository.uin-malang.ac.id/14789/7/14789.pdf
Ryan, A., Patel, P., Ratrey, P., O’Connor, P. M., O’Sullivan, J., Ross, R. P., Hill, C., & Hudson, S. P. (2023). The development of a solid lipid nanoparticle (SLN)-based lacticin 3147 hydrogel for the treatment of wound infections. Drug Delivery and Translational Research, 13(9), 2407–2423. https://doi.org/10.1007/s13346-023-01332-9
Seo, Y., Lim, H., Park, H., Yu, J., An, J., Yoo, H. Y., & Lee, T. (2023). Recent Progress of Lipid Nanoparticles-Based Lipophilic Drug Delivery: Focus on Surface Modifications. Pharmaceutics, 15(3), 772. https://doi.org/10.3390/pharmaceutics15030772
Sholihah, A. A. (2024). Pengaruh VCO terhadap aktivitas krim ekstrak daun teh hijau (camellia sinensis L.) sebagai antibakteri penyebab jerawat (propionibacterium acnes): Studi in vitro dan in silico.
Syama, K., Jakubek, Z. J., Chen, S., Zaifman, J., Tam, Y. Y. C., & Zou, S. (2022). Development of lipid nanoparticles and liposomes reference materials (II): Cytotoxic profiles. Scientific Reports, 12(1), 18071. https://doi.org/10.1038/s41598-022-23013-2
Tukiran, N. A., Ahmad Anuar, N. A., & Jamaludin, M. A. (2023a). Gelatin In Halal Pharmaceutical Products. Malaysian Journal of Syariah and Law, 11(1). https://doi.org/10.33102/mjsl.vol11no1.344
Tukiran, N. A., Ahmad Anuar, N. A., & Jamaludin, M. A. (2023b). GELATIN IN HALAL PHARMACEUTICAL PRODUCTS. Malaysian Journal of Syariah and Law, 11(1). https://doi.org/10.33102/mjsl.vol11no1.344
Yulianti, E., Prasetyo, O. B., & Mubasyiroh, M. (2025). Formulasi Nanoemulsi Serum Antibakteri Penyebab Jerawat (propionibacterium Acnes) Ekstrak Daun Teh Hijau (Camellia sinensis): Studi in Vitro dan in Siliko Serta Perspektif Islam https://repository.uin-malang.ac.id/25476/
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Azka Azhari Rasyida
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work’s authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
